NCT02177136.
Trial name or title | NCT02177136. |
Methods | Randomised, double‐blind, placebo‐controlled trial. |
Participants | Patients with primary sclerosing cholangitis. |
Interventions | Obeticholic acid vs placebo. |
Outcomes | Adverse events. |
Starting date | December 2014. |
Contact information | kate.mckeown@interceptpharma.com |
Notes |